Genmab A/s
(OTC) GNMSF
Genmab A/s Financials at a Glance
Market Cap
$16.84B
Revenue (TTM)
$13.01B
Net Income (TTM)
$3.89B
EPS (TTM)
$15.43
P/E Ratio
17.57
Dividend
$0.00
Beta (Volatility)
0.36 (Low)
Dividend
$0.00
Beta (Volatility)
0.36 (Low)
Price
$273.25
Volume
80
Open
$272.75
Price
$273.25
Volume
80
Open
$272.75
Previous Close
$273.25
Daily Range
$272.75 - $273.25
52-Week Range
$188.05 - $352.00
Dividend
$0.00
Beta (Volatility)
0.36 (Low)
Price
$273.25
Volume
80
Open
$272.75
Previous Close
$273.25
Daily Range
$272.75 - $273.25
52-Week Range
$188.05 - $352.00
GNMSF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genmab A/s
Industry
Biotechnology
Sector
Health CareEmployees
3,029
CEO
Jan G. J. van de Winkel, PhD
Website
www.genmab.comHeadquarters
Copenhagen, 1560, DK
GNMSF Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
37%
Net Income Margin
21%
Return on Equity
18%
Return on Capital
59%
Return on Assets
30%
Earnings Yield
5.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$16.84B
Shares Outstanding
61.63M
Volume
80
Short Interest
0.00%
Avg. Volume
40.323
Financials (TTM)
Gross Profit
$3.53B
Operating Income
$1.29B
EBITDA
$1.37B
Operating Cash Flow
$1.23B
Capital Expenditure
$38.30M
Free Cash Flow
$1.19B
Cash & ST Invst.
$1.71B
Total Debt
$5.54B
Genmab A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.06B
-83.5%
Gross Profit
$981.37M
-83.9%
Gross Margin
92.34%
N/A
Market Cap
$16.84B
N/A
Market Cap/Employee
$6.38M
N/A
Employees
2,638
N/A
Net Income
$31.14M
-99.2%
EBITDA
$244.09M
-89.6%
Quarterly Fundamentals
Net Cash
$3.83B
-119.1%
Accounts Receivable
$1.15B
-82.9%
Inventory
$17.92M
-71.1%
Long Term Debt
$5.25B
+459.8%
Short Term Debt
$289.71M
+214.9%
Return on Assets
30.26%
N/A
Return on Invested Capital
59.45%
N/A
Free Cash Flow
$289.23M
-89.0%
Operating Cash Flow
$302.44M
-88.8%